BIOTRONIK Remote Cardiac Monitoring

Access Free Exclusive Content Now

Remote monitoring allows patient devices to communicate and provide key patient data to physicians, while ensuring patients are monitored continuously. Dr. Borge from the US explains how physicians can set parameters within BIOTRONIK’s Home Monitoring so that he is alerted – in real-time – on the status of the patient. This function supports cost-effective and comfortable patient care at home, so you can allocate your time wisely, treating the patients that most need it.

BIOMONITOR IIIm

Home Monitoring

Patient App

A small lightweight ICM with a state-of-the-art design which significantly reduces false positives and delivers high quality sensing for maximum diagnostic precision.

The pioneer remote monitoring solution in the industry, enables physicians to monitor their patients’ clinical status and automatically notifies physicians of trends and medical events anytime, anywhere.

Provides physicians with crucial symptom data whilst giving patients additional opportunity for engagement.

Often after implanting cardiac devices, patients might have to stay overnight and have a series of in-office follow-ups. Dr. Mazzini from the US describes how in his experience, remote monitoring allows for, in some cases, same-day discharges, still enabling physicians to check on patients safely and remotely.

When partnered with ICMs, remote monitoring is central in to expediting diagnosis. “A diagnosis delayed is a diagnosis denied,” Dr. Gallagher from the UK explains how remote monitoring provides real-time data to physicians without the need to wait until the six or 12-month follow up, where in the case of patients at the risk of stroke, it might already be too late.

PRIVACY STATEMENT

LEGAL DISCLAIMER

IMPRINT

GENERAL TERMS AND CONDITIONS

What Is Remote Cardiac Monitoring?

Remote cardiac monitoring is a digital network that delivers a complete system for diagnosis and patient management – remotely – supported by a range of implantable cardiac devices. Here you will find a collection of resources that help demonstrate the functionality and benefits of this system. Sign up above to receive additional exclusive and current information on this topic.

There has been a significant increase in the usage of insertable cardiac monitors to detect paroxysmal arrhythmias, and as these devices get smaller, they must maintain their ability to deliver reliable, accurate and readable ECGs. When used in conjunction with remote monitoring, they can make a real difference in reaching a speedy diagnosis and therapy.

Insertable Cardiac Monitors (ICM)

close x

When paired with remote monitoring, pacemakers, ICDs and CRT devices can continue to improve quality of life and deliver life-saving monitoring/diagnosis and therapy to patients around the globe, while helping reduce the need for face-to-face follow ups2 ,the risk of hospitalizations and even death.

Therapeutic Devices

close x

In the digital age, patients want to be more involved with their treatment. When used in conjunction with the remote monitoring and ICM systems, patient apps complete the network to offer a higher level of engagement for patients, and crucial data on symptoms to physicians which is valuable in detecting symptom-rhythm correlation.

Patient App

close x

Atrial fibrillation (AF) is a very common condition, affecting over 33 million people worldwide(7). Insertable cardiac monitors help diagnose AF – a leading cause of stroke – by constantly monitoring patients. UK’s Dr. Kaba tells us that despite AF being predominantly asymptomatic, ICMs help physicians manage AF and reduce the risk of stroke.

No two ICMs are created equal. Dr. Yunus from the US explains that while they are key to helping diagnose syncope, there are key differences between offerings of ICMs in the market, particularly relating to data transmission, reporting and the reliability of actionable insights.

Want to Know More?

BIOTRONIK has a suite of innovative solutions that provide physicians with remote monitoring capabilities. Find out more in the links below.

A full suite of pacemakers, ICDs and CRT devices that are automatically enabled with remote monitoring compatibilities.

Implantable Cardiac Devices

More Information

BLOG

The TRUST trial showed early detection of arrhythmias with remote monitoring.

TRUST

Home Monitoring and injectable cardiac monitors (Dr. Awad, Cardiac EP, Mercy Clinic, St. Louis)

Remote Monitoring and ICMs

BLOG

Home Monitoring shown to safely and efficiently replace face-to-face follow-ups for pacemaker patients.

At-Home

MEDIA RELEASE

73% fewer hospitalizations due to inappropriate shocks

Earlier detection of atrial fibrillation

Significant reduction of face-to-face follow-ups

RM-ALONE

ECOST

TRUST

How It Can Help You and Your Patients

Remote Cardiac Monitoring.

Reliable Care and Diagnosis.

Insertable Cardiac Monitors

Patient Apps

Remote Monitoring

Therapeutic Devices

Insertable Cardiac Monitors

There has been a significant increase in the usage of insertable cardiac monitors to detect proxymal arrhythmias, and as these devices get smaller, they must maintain their ability to deliver reliable, accurate and readable ECGs. When used in conjunction with high performing remote monitoring system, ICMs can make a real difference in reaching a speedy diagnosis and therapy.

Remote Monitoring

Remote monitoring can play a significant role in patient management during and beyond COVID-19. Studies have demonstrated that face-to-face visits can be safely and efficiently reduced (1,2), helping minimize the risk to patients and those working on the frontlines of healthcare, while still supporting positive patients outcomes.

Therapeutic Devices

When paired with remote monitoring, pacemakers, ICDs and CRT devices can deliver life-saving monitoring, diagnosis and therapy (1,3,4,5,6) to patients around the globe, while helping reduce the need for face-to-face follow-ups (2), the risk of hospitalizations and even death.

Patient App

1 TRUST Study. Varma et al., Circulation (2010), 122: 325-332 2 RM-ALONE Study. García-Fernández FJ et al., European Heart Journal (2019), 23: 1837-1846 3 ECOST Study. Guedon-Moreau et al., European Heart Journal (2013), 34: 605-614 4 IN-TIME Study. Hindricks et al., The Lancet (2014), 384: 583-590 5 TRUECOIN Study. Hindricks et al., European Heart Journal (2017), 1749–1755 6 Ricci et al., Europace (2010), 12: 676 7 Worldwide Epidemiology of Atrial Fibrillation, A Global Burden of Disease 2010 Study. Centers for Disease Control and Prevention